EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Strategy of Immunologic Control of HIV-1 with Structured Treatment Interruptions (STIs)

R B Moss, F C Jensen, D J Carlo, M R Wallace

Current Drug Target -Infectious Disorders · 2001

DOI: 10.2174/1568005013343236 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Drug Target -Infectious Disorders, 2001. Verfasst von R B Moss und 3 weiteren Autor:innen. Beteiligte Einrichtung: Immune Response Corporation, 5935 Darwin Court, Carlsbad, CA 92008, USA. Hauptthemen laut MEDLINE: Antiretroviral Therapy, Highly Active. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiretroviral Therapy, Highly ActiveAIDS VaccinesAcquired Immunodeficiency SyndromeCD4-Positive T-LymphocytesHIV-1Humans

Substanzen

AIDS Vaccines

Autor:innen und Institutionen

  • Immune Response Corporation, 5935 Darwin Court, Carlsbad, CA 92008, USA.

Zitieren

APA

Moss, R. B., Jensen, F. C., Carlo, D. J., & Wallace, M. R. (2001). The Strategy of Immunologic Control of HIV-1 with Structured Treatment Interruptions (STIs). Current Drug Target -Infectious Disorders. https://doi.org/10.2174/1568005013343236

Vancouver

Moss RB, Jensen FC, Carlo DJ, Wallace MR. The Strategy of Immunologic Control of HIV-1 with Structured Treatment Interruptions (STIs). Current Drug Target -Infectious Disorders. 2001. doi:10.2174/1568005013343236

BibTeX
@article{Moss2001,
  author = {Moss, R B and Jensen, F C and Carlo, D J and Wallace, M R},
  title = {The Strategy of Immunologic Control of HIV-1 with Structured Treatment Interruptions (STIs)},
  journal = {Current Drug Target -Infectious Disorders},
  year = {2001},
  doi = {10.2174/1568005013343236}
}
Kostenlos starten →